BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 17217542)

  • 1. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales.
    van Woerden HC; Wilkinson J; Heaven M; Merrifield J
    BMC Nephrol; 2007 Jan; 8():1. PubMed ID: 17217542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006.
    Kramer A; Stel V; Zoccali C; Heaf J; Ansell D; Grönhagen-Riska C; Leivestad T; Simpson K; Pálsson R; Postorino M; Jager K;
    Nephrol Dial Transplant; 2009 Dec; 24(12):3557-66. PubMed ID: 19820003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal Epidemiology and Information Network: 2007 annual report ].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal replacement therapy in the Canary Islands: demographic and survival analysis.
    Lorenzo V; Sanchez E; Vega N; Hernandez D
    J Nephrol; 2006; 19(1):97-103. PubMed ID: 16523433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephrology and renal replacement therapy in Romania--transition still continues (Cinderella story revisited).
    Mircescu G; Capsa D; Covic M; Caprioara MG; Gluhovschi G; Golea O; Ursea N; Gârneata L; Cepoi V; Constantinovici N; Covic A
    Nephrol Dial Transplant; 2004 Dec; 19(12):2971-80. PubMed ID: 15574995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional and social inequalities in chronic renal replacement therapy in Denmark.
    Hommel K; Rasmussen S; Kamper AL; Madsen M
    Nephrol Dial Transplant; 2010 Aug; 25(8):2624-32. PubMed ID: 20207710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pre-occupying increase in diabetes as cause for terminal kidney failure. Evaluation of treatment strategies].
    Pérez García R; Rodríguez Benítez P; Dall'Anesse C; Gómez Campderá F; Valderrábano F
    An Med Interna; 2001 Apr; 18(4):175-80. PubMed ID: 11496535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the differences in epidemiology of treated ESRD between Germany and England and Wales.
    Caskey FJ; Schober-Halstenberg HJ; Roderick PJ; Edenharter G; Ansell D; Frei U; Feest TG
    Am J Kidney Dis; 2006 Mar; 47(3):445-54. PubMed ID: 16490623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the difference in incidence of renal replacement therapy between Flanders and the Netherlands--investigation of explanatory variables.
    Visser A; Noordzij M; Gansevoort RT; Van Biesen W; Reijneveld SA; Jager KJ; de Jong PE; Izaks GJ; Dijkstra GJ; De Meester J; Hoitsma AJ; Franssen CF
    Nephrol Dial Transplant; 2012 Feb; 27(2):803-9. PubMed ID: 21669881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with diabetic nephropathy on renal replacement therapy in England and Wales.
    Nitsch D; Burden R; Steenkamp R; Ansell D; Byrne C; Caskey F; Roderick P; Feest T
    QJM; 2007 Sep; 100(9):551-60. PubMed ID: 17681992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.
    Goovaerts T; Jadoul M; Goffin E
    Nephrol Dial Transplant; 2005 Sep; 20(9):1842-7. PubMed ID: 15919693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in renal replacement therapy in Turkey, 1996-2008.
    Süleymanlar G; Serdengeçti K; Altiparmak MR; Jager K; Seyahi N; Erek E;
    Am J Kidney Dis; 2011 Mar; 57(3):456-65. PubMed ID: 21335249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All patients receiving renal replacement therapy in the United Kingdom in 2005 (chapter 4).
    Farrington K; Rao R; Stenkamp R; Ansell D; Feest T
    Nephrol Dial Transplant; 2007 Aug; 22 Suppl 7():vii30-50. PubMed ID: 17724051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2006 ERA-EDTA Registry annual report: a précis.
    Stel VS; Kramer A; Zoccali C; Jager KJ
    J Nephrol; 2009; 22(1):1-12. PubMed ID: 19229813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Network and epidemiologic information in nephrology: Kidney report 2009].
    Nephrol Ther; 2011 Sep; 7 Suppl 2():S43-214. PubMed ID: 21943880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of renal service provision in south and mid Wales.
    Christie S; Morgan G; Heaven M; Sandifer Q; Woerden Hv
    Public Health; 2005 Aug; 119(8):738-42. PubMed ID: 15949526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related differences in renal function at onset of renal replacement therapy in chronic kidney disease stage 5 patients.
    Balogun SA; Balogun RA; Evans J
    QJM; 2006 Sep; 99(9):595-9. PubMed ID: 16905750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.